Imaginostics, Inc.
PrivateLast Round
Series A
Mar 1, 2026
Est. Valuation
$9M
Total Funding Raised
$3.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Imaginostics, Inc. operates in Healthcare & Life Sciences and is based in Orlando, Florida. Its latest recorded funding round was a VC Round in October 2024.
Imaginostics, Inc. is a health technology company that develops a quantitative vascular imaging platform and MRI biomarkers for the early detection and characterization of complex neurological and chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Imaginostics, Inc. Comparables
Compare Imaginostics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| bioProtonics | 85% | |
| Gradience Health | 82% | |
| BrainSpec | 81% |
For institutional investors. Book with your work email.
Imaginostics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 1, 2026 | ||||
| VC Round | Oct 1, 2024 | ||||
| Grant | Nov 1, 2022 | ||||
| Grant | Sep 15, 2022 | ||||
| Grant | Sep 6, 2022 | ||||
Grant | Jan 11, 2022 |
For institutional investors. Book with your work email.
Imaginostics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Mental Health | Grant |
| Ideaship | Seed |
| NIH RADx | Grant |
| National Institute on Aging | Grant |
| Alzheimer's Drug Discovery Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Open roles increased from 0 to 4, representing 67% of headcount.
- May 18, 2026
Monthly visitors increased 260% MoM, reaching 2.4K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 22, 2026
Imaginostics's Co-Founder and Chief Scientific Officer moderates the “Rapid Innovation and Adoption” panel at State of Medical City 2026 in Florida on Sep 18th '26.
For institutional investors. Book with your work email.
Imaginostics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Imaginostics, Inc.'s valuation, stock price, and market status.
Is Imaginostics, Inc. a public or private company?
Imaginostics, Inc. is a private company.
What is the current stock price of Imaginostics, Inc.?
Imaginostics, Inc. is a private company, so its shares have no public market price. Caplight tracks Imaginostics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Imaginostics, Inc. worth (valuation)?
Imaginostics, Inc.'s valuation is estimated at $9.0M based on funding round data.
Can I buy Imaginostics, Inc. stock?
Imaginostics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Imaginostics, Inc.'s last funding round?
Imaginostics, Inc.'s most recent funding round was Series A on March 1, 2026.
Who are the main investors in Imaginostics, Inc.?
Key investors in Imaginostics, Inc. include Ideaship.
Will Imaginostics, Inc. IPO soon?
No public IPO plans have been announced for Imaginostics, Inc..
How can I track Imaginostics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Imaginostics, Inc.'s shares on secondary markets.